Earnings Call Summary | KIMBERLY-CLARK DE MEXICO SAB DE CV ADR-REPR 5 ORD'A'NPV(KCDMY.US) Q2 2024 Earnings Conference
Earnings Call Summary | KIMBERLY-CLARK DE MEXICO SAB DE CV ADR-REPR 5 ORD'A'NPV(KCDMY.US) Q2 2024 Earnings Conference
The following is a summary of the Kimberly-Clark De México, S. A. B. De C. V. (KCDMY) Q2 2024 Earnings Call Transcript:
以下是 Kimberly-Clark De México, S.A. b. De C.V. (KCDMY) 2024 年第二季度業績電話會議記錄摘要：
Financial Performance:
財務業績：
Kimberly-Clark de Mexico reported record Q2 net sales of MXN 14.1 billion, a 2.6% increase year-over-year.
EBITDA grew to MXN 4 billion, a 14.8% increase, with a margin improvement to 28.7%.
Net income rose to MXN 2.1 billion, an 18.5% increase, with earnings per share at MXN 0.69.
Cost of goods sold decreased by 4%, with cost reduction programs yielding about MXN 400 million in savings.
墨西哥金伯利-克拉克報告稱，第二季度淨銷售額爲創紀錄的141墨西哥披索，同比增長2.6％。
息稅折舊攤銷前利潤增長至40墨西哥披索，增長14.8％，利潤率提高至28.7％。
淨收入增至21墨西哥披索，增長18.5％，每股收益爲0.69墨西哥披索。
商品銷售成本下降了4％，成本削減計劃節省了約40000萬墨西哥披索。
Business Progress:
業務進展：
Continued strong performance in the Consumer Products segment and significant growth in exports of finished products by 67.7%.
Innovations launched in key product categories like Huggies Diapers and Kotex Fenpatch.
Investments in manufacturing to enhance flexibility in using cost-effective materials.
消費品板塊持續強勁表現，成品出口大幅增長67.7％。
Huggies Diapers 和 Kotex Fenpatch 等關鍵產品類別推出了創新。
投資製造業以提高使用具有成本效益的材料的靈活性。
Opportunities:
機會：
Expectation of continued strong sales driven by innovations and commercial execution.
Positive trends expected in tissue parent rolls and exports due to optimizing the North American supply chain.
在創新和商業執行的推動下，預計銷售將持續強勁。
由於北美供應鏈的優化，紙巾母卷和出口預計將呈現積極趨勢。
Risks:
風險：
Impact of rising pulp costs and exchange rate fluctuations on financial results.
Persistent competition and price sensitivity in the market could affect volume and margin performance.
紙漿成本上漲和匯率波動對財務業績的影響。
市場的持續競爭和價格敏感性可能會影響成交量和利潤表現。
More details: KIMBERLY-CLARK DE MEXICO SAB DE CV ADR-REPR 5 ORD'A'NPV IR
更多詳情：Kimberly-Clark DE MEXICO Sab DE CV ADR-REPR 5 ORD'A'NPV 投資者關係
Tips: This article is generated by AI. The accuracy of the content can not be fully guaranteed. For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.
提示：本文由 AI 生成。無法完全保證內容的準確性。欲了解更多詳情，請訪問投資者關係網站。本文僅供投資者參考，不構成任何投資建議。